Does tissue factor and tissue factor pathway inhibitor over expression, play a role in the development of venous thromboembolism in ovarian cancer patients?
F. Abu Saadeh, L. Norris, S. O'Toole, R. Langhe, J.J. O'Leary, N. GleesonVolume:
129
Year:
2012
Language:
english
DOI:
10.1016/s0049-3848(12)70074-9
File:
PDF, 65 KB
english, 2012